96 related articles for article (PubMed ID: 20143389)
1. The marine compound spongistatin 1 targets pancreatic tumor progression and metastasis.
Rothmeier AS; Schneiders UM; Wiedmann RM; Ischenko I; Bruns CJ; Rudy A; Zahler S; Vollmar AM
Int J Cancer; 2010 Sep; 127(5):1096-105. PubMed ID: 20143389
[TBL] [Abstract][Full Text] [Related]
2. Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice.
Bauer TW; Liu W; Fan F; Camp ER; Yang A; Somcio RJ; Bucana CD; Callahan J; Parry GC; Evans DB; Boyd DD; Mazar AP; Ellis LM
Cancer Res; 2005 Sep; 65(17):7775-81. PubMed ID: 16140945
[TBL] [Abstract][Full Text] [Related]
3. Hepatocyte growth factor inhibits anoikis of pancreatic carcinoma cells through phosphatidylinositol 3-kinase pathway.
Watanabe S; Kishimoto T; Yokosuka O
Pancreas; 2011 May; 40(4):608-14. PubMed ID: 21499215
[TBL] [Abstract][Full Text] [Related]
4. BH3-only proteins Mcl-1 and Bim as well as endonuclease G are targeted in spongistatin 1-induced apoptosis in breast cancer cells.
Schneiders UM; Schyschka L; Rudy A; Vollmar AM
Mol Cancer Ther; 2009 Oct; 8(10):2914-25. PubMed ID: 19808980
[TBL] [Abstract][Full Text] [Related]
5. Leptin signaling enhances cell invasion and promotes the metastasis of human pancreatic cancer via increasing MMP-13 production.
Fan Y; Gan Y; Shen Y; Cai X; Song Y; Zhao F; Yao M; Gu J; Tu H
Oncotarget; 2015 Jun; 6(18):16120-34. PubMed ID: 25948792
[TBL] [Abstract][Full Text] [Related]
6. EFEMP1 expression promotes in vivo tumor growth in human pancreatic adenocarcinoma.
Seeliger H; Camaj P; Ischenko I; Kleespies A; De Toni EN; Thieme SE; Blum H; Assmann G; Jauch KW; Bruns CJ
Mol Cancer Res; 2009 Feb; 7(2):189-98. PubMed ID: 19208748
[TBL] [Abstract][Full Text] [Related]
7. Promoted cancer growth by stimulating cell proliferation and decreasing apoptosis using a lentivirus-based EphB2 RNAi in pancreatic carcinoma CFPAC-1 cells.
Hua YQ; Ouyang HQ; Chen Z; Meng ZQ; Luo JM; Lin JH; Zhou ZH; Chen H; Wang K; Liu LM
Biomed Pharmacother; 2011 Mar; 65(2):123-31. PubMed ID: 21292437
[TBL] [Abstract][Full Text] [Related]
8. LY2109761, a novel transforming growth factor beta receptor type I and type II dual inhibitor, as a therapeutic approach to suppressing pancreatic cancer metastasis.
Melisi D; Ishiyama S; Sclabas GM; Fleming JB; Xia Q; Tortora G; Abbruzzese JL; Chiao PJ
Mol Cancer Ther; 2008 Apr; 7(4):829-40. PubMed ID: 18413796
[TBL] [Abstract][Full Text] [Related]
9. Identification of stemonamide synthetic intermediates as a novel potent anticancer drug with an apoptosis-inducing ability.
Li YY; Wang YY; Taniguchi T; Kawakami T; Baba T; Ishibashi H; Mukaida N
Int J Cancer; 2010 Jul; 127(2):474-84. PubMed ID: 19921695
[TBL] [Abstract][Full Text] [Related]
10. Roles of Fyn in pancreatic cancer metastasis.
Chen ZY; Cai L; Bie P; Wang SG; Jiang Y; Dong JH; Li XW
J Gastroenterol Hepatol; 2010 Feb; 25(2):293-301. PubMed ID: 19968749
[TBL] [Abstract][Full Text] [Related]
11. Small molecule 1'-acetoxychavicol acetate suppresses breast tumor metastasis by regulating the SHP-1/STAT3/MMPs signaling pathway.
Wang J; Zhang L; Chen G; Zhang J; Li Z; Lu W; Liu M; Pang X
Breast Cancer Res Treat; 2014 Nov; 148(2):279-89. PubMed ID: 25301089
[TBL] [Abstract][Full Text] [Related]
12. Medroxyprogesterone acetate inhibits human pancreatic carcinoma cell growth by inducing apoptosis in association with Bcl-2 phosphorylation.
Abe M; Yamashita J; Ogawa M
Cancer; 2000 May; 88(9):2000-9. PubMed ID: 10813710
[TBL] [Abstract][Full Text] [Related]
13. Hydrogen peroxide mediates hyperglycemia-induced invasive activity via ERK and p38 MAPK in human pancreatic cancer.
Li W; Ma Z; Ma J; Li X; Xu Q; Duan W; Chen X; Lv Y; Zhou S; Wu E; Ma Q; Huo X
Oncotarget; 2015 Oct; 6(31):31119-33. PubMed ID: 26439801
[TBL] [Abstract][Full Text] [Related]
14. Effect of Src kinase inhibition on metastasis and tumor angiogenesis in human pancreatic cancer.
Ischenko I; Guba M; Yezhelyev M; Papyan A; Schmid G; Green T; Fennell M; Jauch KW; Bruns CJ
Angiogenesis; 2007; 10(3):167-82. PubMed ID: 17486419
[TBL] [Abstract][Full Text] [Related]
15. Anticancer and antimetastatic activities of Renieramycin M, a marine tetrahydroisoquinoline alkaloid, in human non-small cell lung cancer cells.
Halim H; Chunhacha P; Suwanborirux K; Chanvorachote P
Anticancer Res; 2011 Jan; 31(1):193-201. PubMed ID: 21273598
[TBL] [Abstract][Full Text] [Related]
16. Pancreatic tumor mass in a xenograft mouse model is decreased by treatment with therapeutic stem cells following introduction of therapeutic genes.
Kim DJ; Yi BR; Lee HR; Kim SU; Choi KC
Oncol Rep; 2013 Sep; 30(3):1129-36. PubMed ID: 23807450
[TBL] [Abstract][Full Text] [Related]
17. Interstitial chemotherapy with ricin-loaded thermosensitive hydrogel in pancreatic cancer xenograft.
Chen ZK; Lin LW; Weng XH; Xue ES; Lin YH
Hepatobiliary Pancreat Dis Int; 2009 Aug; 8(4):418-23. PubMed ID: 19666413
[TBL] [Abstract][Full Text] [Related]
18. Investigation of the marine compound spongistatin 1 links the inhibition of PKCalpha translocation to nonmitotic effects of tubulin antagonism in angiogenesis.
Rothmeier AS; Ischenko I; Joore J; Garczarczyk D; Fürst R; Bruns CJ; Vollmar AM; Zahler S
FASEB J; 2009 Apr; 23(4):1127-37. PubMed ID: 19056838
[TBL] [Abstract][Full Text] [Related]
19. T-18, a stemonamide synthetic intermediate inhibits Pim kinase activity and induces cell apoptosis, acting as a potent anticancer drug.
Wang Z; Li XM; Shang K; Zhang P; Wang CF; Xin YH; Zhou L; Li YY
Oncol Rep; 2013 Mar; 29(3):1245-51. PubMed ID: 23314349
[TBL] [Abstract][Full Text] [Related]
20. [Effect of ZGDHu-1 on proliferation and apoptosis of A549 cells in vitro and antitumor activity in vivo].
Zhou YL; Hu WX; Lü YP; Qiu LN; Wang WS; Yang ZY; Liu JD; Rao GW
Yao Xue Xue Bao; 2007 Jan; 42(1):26-34. PubMed ID: 17520803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]